Theoretical structural explanation for Group I and Group II, type 2A von Willebrand disease mutations
Lee A. O’Brien(University of Wisconsin–Madison), David Lillicrap(Queen's University), Donald F. Weaver(Allen Institute for Brain Science), Jeffrey J. Sutherland(Dalhousie University)
Cited by 22
Related Papers
The mutational spectrum of type 1 von Willebrand disease: results from a Canadian cohort study
|Blood|2006|351
A Comparison of Methods for Modeling Quantitative Structure−Activity Relationships
|Journal of Medicinal Chemistry|2004|233
Spline-Fitting with a Genetic Algorithm: A Method for Developing Classification Structure−Activity Relationships
|Journal of Chemical Information and Computer Sciences|2003|198
Genetic linkage and association analysis in type 1 von Willebrand disease: results from the Canadian Type 1 VWD Study
|Journal of Thrombosis and Haemostasis|2006|86